Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11972)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 26, 2019 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song H, Zhong LP, He J, Huang Y, Zhao YX. Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clin Cases 2019; 7(16): 2143-2154 [PMID: 31531310 DOI: 10.12998/wjcc.v7.i16.2143] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i16/2143.htm |
| Number | Citing Articles |
| 1 |
Fang Huang, Chuanjing Dai, Youni Zhang, Yuqi Zhao, Yigang Wang, Guoqing Ru. Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.889403
|
| 2 |
Amir Sasan Mozaffari Nejad, Fatemeh Fotouhi, Parvaneh Mehrbod, Mohsen Keshavarz, Mohammad Yousef Alikhani, Amir Ghaemi. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways. Microbial Pathogenesis 2020; 147: 104438 doi: 10.1016/j.micpath.2020.104438
|
| 3 |
Ying Gao, Hui Ji, Lin Peng, Xiuge Gao, Shanxiang Jiang. Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine. Molecules 2020; 25(11): 2505 doi: 10.3390/molecules25112505
|
| 4 |
Mahalaxmi Iyer, Nandita Ravichandran, Panimalar Abirami Karuppusamy, Roselin Gnanarajan, Mukesh Kumar Yadav, Arul Narayanasamy, Balachandar Vellingiri. . Advances in Protein Chemistry and Structural Biology 2024; doi: 10.1016/bs.apcsb.2023.12.007
|
| 5 |
Carla Giles, Thiru Vanniasinkam. Viral Vectors in Veterinary Vaccine Development. 2021; : 21 doi: 10.1007/978-3-030-51927-8_3
|
| 6 |
Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali. Therapeutic vaccines for colorectal cancer: The progress and future prospect. International Immunopharmacology 2020; 88: 106944 doi: 10.1016/j.intimp.2020.106944
|
| 7 |
Amina Nawal Bahoussi, Pir Tariq Shah, Jia-Qi Zhao, Pei-Hua Wang, Yan-Yan Guo, Changxin Wu, Li Xing. Multiple potential recombination events among Newcastle disease virus genomes in China between 1946 and 2020. Frontiers in Veterinary Science 2023; 10 doi: 10.3389/fvets.2023.1136855
|
| 8 |
Bei Ru Lee, Jeevanathan Kalyanasunandram, Kavitha Murulitharan, Kok Song Lai, Suet Lin Chia, Khatijah Yusoff. Reduced pathogenicity of velogenic NDV strain AF22420-I via site-directed mutagenesis of V gene. Asia Pacific Journal of Molecular Biology and Biotechnology 2021; : 59 doi: 10.35118/apjmbb.2021.029.3.08
|
| 9 |
Guowei Tang, Damei Wu, Minghao Guo, Huashan Li. LncRNA MIR497HG inhibits colorectal cancer progression by the miR-3918/ACTG2 axis. Journal of Genetics 2022; 101(1) doi: 10.1007/s12041-022-01367-w
|
| 10 |
Anne Everts, Melissa Bergeman, Grant McFadden, Vera Kemp. Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses. Biomedicines 2020; 8(11): 474 doi: 10.3390/biomedicines8110474
|
| 11 |
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El-Deiry. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022; 14(4): 1028 doi: 10.3390/cancers14041028
|
| 12 |
Zhihui Ruan, Jiangyang Chi, Yue Kong, Chengcheng Li, Xiaolan Ruan, Xing Zhou, Yanxi Chen, Yongkui Li, Zhen Luo. Natural Oncolysis of Enterovirus 71 in Antitumor Therapy of Colorectal Cancer. Advanced Biology 2023; 7(7) doi: 10.1002/adbi.202200336
|
| 13 |
Deeba Naz, Sajjad ur Rahman, Muhammad Aamir Aslam, Faqir Muhammad. Newcastle disease virus in poultry with an interface as a human vector. Veterinary Vaccine 2022; 1(1): 100003 doi: 10.1016/j.vetvac.2022.100003
|
| 14 |
RajLaxmi Sarangi, Sanjukta Mishra, Srikrushna Mahapatra. Cancer Vaccines: A Novel Revolutionized Approach to Cancer Therapy. Indian Journal of Clinical Biochemistry 2024; doi: 10.1007/s12291-024-01201-3
|
| 15 |
Esam Bashir Yahya, Amaal Mohammed Alqadhi. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sciences 2021; 269: 119087 doi: 10.1016/j.lfs.2021.119087
|
| 16 |
Kousain Kousar, Faiza Naseer, Maisa Siddiq Abduh, Sadia Anjum, Tahir Ahmad. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1175535
|
| 17 |
Seyed-Mahmood Seyed-Khorrami, Arezou Azadi, Nasrin Rastegarvand, Ala Habibian, Hoorieh Soleimanjahi, Marek J. Łos. A promising future in cancer immunotherapy: Oncolytic viruses. European Journal of Pharmacology 2023; 960: 176063 doi: 10.1016/j.ejphar.2023.176063
|
| 18 |
Upasana Pathak, Ramprasad B. Pal, Nagesh Malik. The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus. Life 2023; 13(8): 1626 doi: 10.3390/life13081626
|
| 19 |
Volker Schirrmacher. New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection. Biomedicines 2020; 8(3): 55 doi: 10.3390/biomedicines8030055
|
| 20 |
Li-Feng Hu, Huan-Rong Lan, Dong Huang, Xue-Min Li, Ke-Tao Jin. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.769305
|
| 21 |
Peter Anto Johnson, Alyssa Wu, John Christy Johnson, Zachary Schauer, Terrence Wu, Francis Fernandes, Reinette Schabert, Austin Mardon. Advances in DNA- and RNA-Based Oncolytic Viral Therapeutics and Immunotherapies. Applied Microbiology 2022; 2(2): 319 doi: 10.3390/applmicrobiol2020024
|
| 22 |
Mohamed A. Elbehairy, Siba K. Samal, George A. Belov. Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability.
Journal of General Virology
2022; 103(6) doi: 10.1099/jgv.0.001761
|
| 23 |
Deok-Hwan Kim, Jiho Lee, Sungsu Youk, Jei-hyun Jeong, Da-ye Lee, Hyo-seon Ju, Ha-na Youn, Jin-cheol Kim, Soo-bin Park, Ji-eun Park, Ji-yun Kim, Tae-hyeon Kim, Seung-hun Lee, Hyukchae Lee, Lah Mouhamed Abdallah Amal Abdal, Dong-Hun Lee, Pil-Gu Park, Kee-Jong Hong, Chang-Seon Song. Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection. Vaccine 2023; 41(33): 4787 doi: 10.1016/j.vaccine.2023.05.071
|